exhibit 38 - weitzlux.com · ppar-alpha receptor knockout mice, i.e., in mice where ppar-alpha...

32
EXHIBIT 38

Upload: others

Post on 24-Jun-2020

8 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did

EXHIBIT 38

Page 2: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 3: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 4: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 5: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 6: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 7: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 8: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 9: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 10: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 11: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 12: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 13: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 14: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 15: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 16: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 17: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 18: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 19: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 20: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 21: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 22: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 23: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 24: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 25: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 26: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 27: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 28: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 29: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 30: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 31: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did
Page 32: EXHIBIT 38 - weitzlux.com · PPAR-alpha receptor knockout mice, i.e., in mice where PPAR-alpha activation was precluded, even while the prototype PPAR-alpha agonist WY- 14,643 did